Treatment Patterns and Outcomes of Stage III Non-Small Cell Lung Cancer (NSCLC): Real World Evidence of How our Patients Fare

被引:1
作者
Yusuf, D. [1 ]
Walton, R. [2 ]
Hurry, M. [2 ]
Cheung, W. [3 ,4 ]
机构
[1] Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada
[2] Astrazeneca Canada, Mississauga, ON, Canada
[3] Univ Calgary, Med, Calgary, AB, Canada
[4] Alberta Hlth Serv, Calgary, AB, Canada
关键词
outcomes; Treatments; NSCLC;
D O I
10.1016/j.jtho.2018.08.967
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.15-34
引用
收藏
页码:S626 / S626
页数:1
相关论文
共 50 条
  • [1] Real-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the 'EVIDENCE' study
    Mountzios, Giannis
    Lampaki, Sofia
    Linardou, Helena
    Georgoulias, Vassilis
    Mavroudis, Dimitrios
    Anevlavis, Stavros
    Charpidou, Andriani
    Lykka, Maria
    Spyratos, Dionysis
    Sarris, Evangelos G.
    Somarakis, Alvertos
    Papista, Christina
    Glentis, Alexandros
    Nikolaou, Aristeidis
    Paparepa, Zoe
    Papageorgiou, Foteini
    Syrigos, Konstantinos N.
    FUTURE ONCOLOGY, 2025, 21 (04) : 447 - 462
  • [2] Stage IIIA Non-Small Cell Lung Cancer (NSCLC): Outcomes by Treatment Strategy
    Carroway, W. P.
    Jiang, S-F.
    Velotta, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S588 - S589
  • [3] Treatment Patterns and Survival of Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Era of Novel Therapies
    Yusuf, D.
    Hurry, M.
    Walton, R.
    Cheung, W.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1002 - S1002
  • [4] Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa-KINDLE Study
    Jazieh, A. R.
    Saglam, E. Kaytan
    Onal, H. C.
    Abdelkader, Y.
    Gaafar, R.
    Dawoud, E.
    Nassar, M.
    Alshorbagy, D.
    El Ashry, H.
    Elsayed, M.
    CLINICAL LUNG CANCER, 2022, 23 (04) : 364 - 373
  • [5] Integration of Durvalumab into the Treatment of Stage III Non-Small Cell Lung Cancer: Real-World Considerations
    Gorgens, S.
    Schreibmann, E.
    Behera, M.
    Steuer, C.
    Pillai, R.
    Owonikoko, T.
    Shelton, J.
    Ramalingam, S.
    Curran, W.
    Higgins, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S588 - S589
  • [6] Retrospective Analysis of Real-World Treatment Patterns and Survival Outcomes for Non-small Cell Lung Cancer Patients in Thailand
    Supaattagorn, S.
    Maneenil, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S603 - S604
  • [7] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [8] Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study
    Moore, Amanda M.
    Nooruddin, Zohra
    Reveles, Kelly R.
    Datta, Paromita
    Whitehead, Jennifer M.
    Franklin, Kathleen
    Alkadimi, Munaf
    Williams, Madison H.
    Williams, Ryan A.
    Smith, Sarah
    Reichelderfer, Renee
    Cotarla, Ion
    Brannman, Lance
    Frankart, Andrew
    Mulrooney, Tiernan
    Hsieh, Kristin
    Simmons, Daniel J.
    Jones, Xavier
    Frei, Christopher R.
    CURRENT ONCOLOGY, 2023, 30 (09) : 8411 - 8423
  • [9] Patterns of care for stage III non-small cell lung cancer in Australia
    Parente, Phillip
    Chan, Bryan A.
    Hughes, Brett G. M.
    Jasas, Kevin
    Joshi, Rohit
    Kao, Steven
    Hegi-Johnson, Fiona
    Hui, Rina
    McLaughlin-Barrett, Sara
    Nordman, Ina
    Stone, Emily
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (03) : 93 - 100
  • [10] Real-World Treatment Patterns and Survival Among Patients with Stage I-III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment
    Seung, Soo Jin
    Moldaver, Daniel
    Hassan, Shazia
    Syed, Iqra
    Shanahan, Marykate
    Liu, Geoffrey
    ONCOLOGY AND THERAPY, 2024, 12 (02) : 311 - 326